Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model

Stroke

Volumn 47, Issue 3, 2016, Pages 895-900

  Kamel, Hooman ^a   Okin, Peter M ^a   Elkind, Mitchell S V ^b   Iadecola, Costantino ^a  

^a FEIL FAMILY BRAIN AND MIND RESEARCH INSTITUTE   (United States)

^b Mailman School of Public Health ^*  (United States)

Author keywords

atrial cardiomyopathy; atrial cardiopathy; atrial fibrillation; cardioembolism; embolic stroke

Indexed keywords

ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; DISEASE COURSE; DISEASE MODEL; HEART ARRHYTHMIA; HUMAN; META ANALYSIS (TOPIC); NEUROPATHOLOGY; NONHUMAN; NOTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; ANIMAL; BIOLOGICAL MODEL; PATHOPHYSIOLOGY; STROKE;

ANIMALS; ATRIAL FIBRILLATION; HUMANS; MODELS, CARDIOVASCULAR; RISK FACTORS; STROKE;

EID: 84959496346     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.115.012004     Document Type: Note

References (51)

1. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837-847. doi: 10.1161/CIRCULATIONAHA.113.005119.
2. Heijman J, Voigt N, Nattel S, Dobrev D. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression. Circ Res. 2014;114:1483-1499. doi: 10.1161/CIRCRESAHA.114.302226.
3. Zimetbaum P, Waks JW, Ellis ER, Glotzer TV, Passman RS. Role of atrial fibrillation burden in assessing thromboembolic risk. Circ Arrhythm Electrophysiol. 2014;7:1223-1229. doi: 10.1161/CIRCEP.114.001356.
4. Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology. 1978;28:973-977.
5. Hill AB. The environment and disease: association or causation Proc R Soc Med. 1965;58:295-300.
6. Manolio TA, Kronmal RA, Burke GL, O'Leary DH, Price TR. Shortterm predictors of incident stroke in older adults. The Cardiovascular Health Study. Stroke. 1996;27:1479-1486.
7. Al-Khatib SM, Thomas L, Wallentin L, Lopes RD, Gersh B, Garcia D, et al. Outcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trial. Eur Heart J. 2013;34:2464-2471. doi: 10.1093/eurheartj/eht135.
8. Vanassche T, Lauw MN, Eikelboom JW, Healey JS, Hart RG, Alings M, et al. Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES. Eur Heart J. 2015;36:281-287a. doi: 10.1093/eurheartj/ehu307.
9. Glotzer TV, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ Arrhythm Electrophysiol. 2009;2:474-480. doi: 10.1161/CIRCEP.109.849638.
10. Nuotio I, Hartikainen JE, Grönberg T, Biancari F, Airaksinen KE. Time to cardioversion for acute atrial fibrillation and thromboembolic complications. JAMA. 2014;312:647-649. doi: 10.1001/jama.2014.3824.
11. Flaker G, Ezekowitz M, Yusuf S, Wallentin L, Noack H, Brueckmann M, et al. Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study. J Am Coll Cardiol. 2012;59:854-855. doi: 10.1016/j. jacc.2011.10.896.
12. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, et al; ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366:120-129. doi: 10.1056/NEJMoa1105575.
13. Chao TF, Liu CJ, Chen SJ, Wang KL, Lin YJ, Chang SL, et al. Atrial fibrillation and the risk of ischemic stroke: does it still matter in patients with a CHA2DS2-VASc score of 0 or 1 Stroke. 2012;43:2551-2555. doi: 10.1161/STROKEAHA.112.667865.
14. Lodder J, Bamford JM, Sandercock PA, Jones LN, Warlow CP. Are hypertension or cardiac embolism likely causes of lacunar infarction Stroke. 1990;21:375-381.
15. Chesebro JH, Fuster V, Halperin JL. Atrial fibrillation-risk marker for stroke. N Engl J Med. 1990;323:1556-1558. doi: 10.1056/NEJM199011293232209.
16. Turakhia MP, Ziegler PD, Schmitt SK, Chang Y, Fan J, Than CT, et al. Atrial fibrillation burden and short-term risk of stroke: case-crossover analysis of continuously recorded heart rhythm from cardiac electronic implanted devices. Circ Arrhythm Electrophysiol. 2015;8:1040-1047. doi: 10.1161/CIRCEP.114.003057.
17. Brambatti M, Connolly SJ, Gold MR, Morillo CA, Capucci A, Muto C, et al; ASSERT Investigators. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation. 2014;129:2094-2099. doi: 10.1161/CIRCULATIONAHA.113.007825.
18. Martin DT, Bersohn MM, Waldo AL, Wathen MS, Choucair WK, Lip GY, et al; IMPACT Investigators. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J. 2015;36:1660-1668. doi: 10.1093/eurheartj/ehv115.
19. Al-Khatib SM, Allen LaPointe NM, Chatterjee R, Crowley MJ, Dupre ME, Kong DF, et al. Rate-and rhythm-control therapies in patients with atrial fibrillation: a systematic review. Ann Intern Med. 2014;160:760-773. doi: 10.7326/M13-1467.
20. De Jong AM, Maass AH, Oberdorf-Maass SU, Van Veldhuisen DJ, Van Gilst WH, Van Gelder IC. Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation. Cardiovasc Res. 2011;89:754-765. doi: 10.1093/cvr/cvq357.
21. Chen PS, Chen LS, Fishbein MC, Lin SF, Nattel S. Role of the autonomic nervous system in atrial fibrillation: pathophysiology and therapy. Circ Res. 2014;114:1500-1515. doi: 10.1161/CIRCRESAHA.114.303772.
22. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001;104:2886-2891.
23. González Toledo ME, Klein FR, Riccio PM, Cassará FP, Munõz Giacomelli F, Racosta JM, et al. Atrial fibrillation detected after acute ischemic stroke: evidence supporting the neurogenic hypothesis. J Stroke Cerebrovasc Dis. 2013;22:e486-e491. doi: 10.1016/j. jstrokecerebrovasdis.2013.05.015.
24. Abboud H, Berroir S, Labreuche J, Orjuela K, Amarenco P; GENIC Investigators. Insular involvement in brain infarction increases risk for cardiac arrhythmia and death. Ann Neurol. 2006;59:691-699. doi: 10.1002/ana.20806.
25. Boiten J, Lodder J. Lacunar infarcts. Pathogenesis and validity of the clinical syndromes. Stroke. 1991;22:1374-1378.
26. Cai H, Li Z, Goette A, Mera F, Honeycutt C, Feterik K, et al. Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke. Circulation. 2002;106:2854-2858.
27. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997;96:1180-1184.
28. Mihm MJ, Yu F, Carnes CA, Reiser PJ, McCarthy PM, Van Wagoner DR, et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation. 2001;104:174-180.
29. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation. 1994;89:724-730.
30. Warraich HJ, Gandhavadi M, Manning WJ. Mechanical discordance of the left atrium and appendage: a novel mechanism of stroke in paroxysmal atrial fibrillation. Stroke. 2014;45:1481-1484. doi: 10.1161/STROKEAHA.114.004800.
31. Stöllberger C, Chnupa P, Kronik G, Brainin M, Finsterer J, Schneider B, et al. Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. ELAT Study Group. Embolism in Left Atrial Thrombi. Ann Intern Med. 1998;128:630-638.
32. Larsen BS, Kumarathurai P, Falkenberg J, Nielsen OW, Sajadieh A. Excessive atrial ectopy and short atrial runs increase the risk of stroke beyond incident atrial fibrillation. J Am Coll Cardiol. 2015;66:232-241. doi: 10.1016/j.jacc.2015.05.018.
33. Kamel H, Elkind MS, Bhave PD, Navi BB, Okin PM, Iadecola C, et al. Paroxysmal supraventricular tachycardia and the risk of ischemic stroke. Stroke. 2013;44:1550-1554. doi: 10.1161/STROKEAHA.113.001118.
34. Kamel H, O'Neal WT, Okin PM, Loehr LR, Alonso A, Soliman EZ. Electrocardiographic left atrial abnormality and stroke subtype in the atherosclerosis risk in communities study. Ann Neurol. 2015;78:670-678. doi: 10.1002/ana.24482.
35. Kamel H, Soliman EZ, Heckbert SR, Kronmal RA, Longstreth WT Jr, Nazarian S, et al. P-wave morphology and the risk of incident ischemic stroke in the Multi-Ethnic Study of Atherosclerosis. Stroke. 2014;45:2786-2788. doi: 10.1161/STROKEAHA.114.006364.
36. Kamel H, Hunter M, Moon YP, Yaghi S, Cheung K, Di Tullio MR, et al. Electrocardiographic left atrial abnormality and risk of stroke: Northern Manhattan Study. Stroke. 2015;46:3208-3212. doi: 10.1161/STROKEAHA.115.009989.
37. Benjamin EJ, D'Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation. 1995;92:835-841.
38. Yaghi S, Moon YP, Mora-McLaughlin C, Willey JZ, Cheung K, Di Tullio MR, et al. Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study. Stroke. 2015;46:1488-1493. doi: 10.1161/STROKEAHA.115.008711.
39. Di Tullio MR, Sacco RL, Sciacca RR, Homma S. Left atrial size and the risk of ischemic stroke in an ethnically mixed population. Stroke. 1999;30:2019-2024.
40. Binici Z, Intzilakis T, Nielsen OW, Køber L, Sajadieh A. Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke. Circulation. 2010;121:1904-1911. doi: 10.1161/CIRCULATIONAHA.109.874982.
41. Kamel H, Bartz TM, Longstreth WT Jr, Okin PM, Thacker EL, Patton KK, et al. Association between left atrial abnormality on ECG and vascular brain injury on MRI in the Cardiovascular Health Study. Stroke. 2015;46:711-716. doi: 10.1161/STROKEAHA.114.007762.
42. Karas MG, Devereux RB, Wiebers DO, Whisnant JP, Best LG, Lee ET, et al. Incremental value of biochemical and echocardiographic measures in prediction of ischemic stroke: the Strong Heart Study. Stroke. 2012;43:720-726. doi: 10.1161/STROKEAHA.111.631168.
43. Barnes ME, Miyasaka Y, Seward JB, Gersh BJ, Rosales AG, Bailey KR, et al. Left atrial volume in the prediction of first ischemic stroke in an elderly cohort without atrial fibrillation. Mayo Clin Proc. 2004;79:1008-1014. doi: 10.4065/79.8.1008.
44. Russo C, Jin Z, Liu R, Iwata S, Tugcu A, Yoshita M, et al. LA volumes and reservoir function are associated with subclinical cerebrovascular disease: the CABL (Cardiovascular Abnormalities and Brain Lesions) study. JACC Cardiovasc Imaging. 2013;6:313-323. doi: 10.1016/j.jcmg.2012.10.019.
45. Disertori M, Quintarelli S, Grasso M, Pilotto A, Narula N, Favalli V, et al. Autosomal recessive atrial dilated cardiomyopathy with standstill evolution associated with mutation of Natriuretic Peptide Precursor A. Circ Cardiovasc Genet. 2013;6:27-36. doi: 10.1161/CIRCGENETICS.112.963520.
46. Marnane M, Duggan CA, Sheehan OC, Merwick A, Hannon N, Curtin D, et al. Stroke subtype classification to mechanism-specific and undetermined categories by TOAST, A-S-C-O, and causative classification system: direct comparison in the North Dublin population stroke study. Stroke. 2010;41:1579-1586. doi: 10.1161/STROKEAHA.109.575373.
47. Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, et al.; CRYSTAL AF Investigators. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370:2478-2486. doi: 10.1056/NEJMoa1313600.
48. Magnani JW, Lopez FL, Soliman EZ, Maclehose RF, Crow RS, Alonso A. P wave indices, obesity, and the metabolic syndrome: the atherosclerosis risk in communities study. Obesity (Silver Spring). 2012;20:666-672. doi: 10.1038/oby.2011.53.
49. Magnani JW, Hylek EM, Apovian CM. Obesity begets atrial fibrillation: a contemporary summary. Circulation. 2013;128:401-405. doi: 10.1161/CIRCULATIONAHA.113.001840.
50. Pathak RK, Middeldorp ME, Lau DH, Mehta AB, Mahajan R, Twomey D, et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol. 2014;64:2222-2231. doi: 10.1016/j. jacc.2014.09.028.
51. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64:e1-e76. doi: 10.1016/j.jacc.2014.03.022.